Osteonecrosis of the jaw in a patient on Denosumab.
Aghaloo
Tara L
TL
Section of Oral and Maxillofacial Surgery, School of Dentistry, University of California, Los Angeles, Los Angeles, CA 90095, USA. taghaloo@dentistry.ucla.edu
Felsenfeld
Alan L
AL
Tetradis
Sotirios
S
D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D015519:Bone Density / Q000502:physiology; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D054893:Cone-Beam Computed Tomography; D000069448:Denosumab; D004890:Erythema / Q000209:etiology; D005260:Female; D005500:Follow-Up Studies; D005870:Giant Cell Tumors / Q000188:drug therapy; D005882:Gingival Diseases / Q000209:etiology; D006801:Humans; D008336:Mandibular Diseases / Q000209:etiology*; D010020:Osteonecrosis / Q000209:etiology*; D053245:RANK Ligand / Q000009:adverse effects*; D011862:Radiography, Panoramic; D012447:Sacrum / Q000187:drug effects; D013125:Spinal Neoplasms / Q000188:drug therapy
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D050071:Bone Density Conservation Agents; D053245:RANK Ligand; D000069448:Denosumab